What this means
Women who take a GLP-1 weight medicine will eat more protein for 12 weeks. Researchers will check body changes, eating habits, health, and well-being before and after.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 30–60
- Where
- 2 sites, including Texas
The science
- Registered title
- Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity)
- Trial ID
- NCT07480109 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Obesity, Women (Between 30 to 60 Years Old)
- What is tested
- Protein Rich Foods
- Sponsor
- University of Texas at Austin
- Ages
- 30 Years to 60 Years
- Dates
- First posted Mar 18, 2026 · updated Jun 9, 2026
Registry summary
Middle-aged women with (overweight/)obesity who will begin or have begun GLP-1 medication use will be recruited to complete a 12-week diet intervention study. For 12-weeks, participants will continue to take their GLP-1 medication and may be provided with protein-rich foods to consume every day. Body composition, eating behavior, health, and well-being will be measured before and after the study.
Sites (2)
- Dell Pediatric Research Center, Austin, Texas, United States
- University of Texas at Austin, Austin, Texas, United States